ZIMMER BIOMET HOLDINGS INC
ZBHNYSETrading Snapshot
- Day Range
- $95.33 – $96.74
- 52-Week Range
- $79.12 – $103.70
- Volume (shares)
- 2,169,877
- Avg Volume (shares)
- —
- Shares Outstanding
- 190.7M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $8.23B
- Last Q Revenue
- $2.18B
- P/E Ratio
- 23.3
- P/S Ratio
- 2.2x
- EPS (TTM)
- $4.20
- Dividend Yield
- 1.00%
- Dilution (1yr)
- −0.9%
ZIMMER BIOMET HOLDINGS INC
ZBH
StockOtter · stockotter.spaceAbout ZIMMER BIOMET HOLDINGS INC
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Multi-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI® System for Use with Zimmer Biomet's Persona® Knee System FREMONT, Calif. and WARSAW, Ind.
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
WARSAW, Ind., Oct. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on Wednesday, No
Critical Review: Zimmer Biomet (NYSE:ZBH) and Butterfly Network (NYSE:BFLY)
Zimmer Biomet (NYSE: ZBH - Get Free Report) and Butterfly Network (NYSE: BFLY - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength o
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shareholders to Get $0.24 Quarterly Dividend
Zimmer Biomet Holdings, Inc. (NYSE: ZBH - Get Free Report) declared a quarterly dividend on Friday, August 28th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.24 per share by the medic